Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide to improve early kidney graft recovery after deceased-donor kidney transplantation
2022-002594-28Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute kidney failure (AKF) and delayed graft function (DGF) comparing Nicotinamide with Placebo (2 arms). Started Jul 2022; status: completed.
02
Drugs
nicotinamide
03
Conditions
acute kidney failure (AKF)delayed graft function (DGF)
Beyond the preview
Go deeper on 2022-002594-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002594-28.